重视烧伤后凝血异常

罗高兴; 张清荣; 钱卫; 李海胜

doi:10.3760/cma.j.cn501225-20221223-00545

重视烧伤后凝血异常

doi: 10.3760/cma.j.cn501225-20221223-00545

陆军军医大学(第三军医大学)第一附属医院全军烧伤研究所，创伤、烧伤与复合伤国家重点实验室，重庆市创面损伤修复与再生重点实验室，重庆　400038

基金项目:

国家自然科学基金国际（地区）合作与交流项目 81920108022

详细信息

通讯作者:
罗高兴，Email：gaoxing.luo@burnstrauma.com

计量
- 文章访问数: 445
- HTML全文浏览量: 91
- PDF下载量: 90
- 被引次数: 0
出版历程
- 收稿日期: 2022-12-23

Paying more attention to burn induced coagulopathy

Institute of Burn Research, State Key Laboratory of Trauma, Burns and Combined Injury, the First Affiliated Hospital of Army Medical University (the Third Military Medical University), Chongqing Key Laboratory for Wound Damage Repair and Regeneration, Chongqing 400038, China

Funds:

International (Regional) Cooperation and Exchange Program of National Natural Science Foundation of China 81920108022

More Information

Corresponding author: Luo Gaoxing, Email: gaoxing.luo@burnstrauma.com

摘要

摘要: 凝血异常是烧伤常见并发症之一，其种类与临床表现差异大，危害性大。但直到目前，临床上对烧伤后凝血异常重视程度仍不够。建议通过加强患者凝血状况监测、手术管理、感染防治、药物的科学合理使用、深静脉血栓的防治、相关临床与基础研究等，以达到进一步有效防治烧伤后凝血异常的目的。
- 烧伤 /
- 凝血异常 /
- 监测 /
- 治疗
Abstract: Burn induced coagulopathy (BIC) is one of the common complications after burn injury. The types and clinical manifestations of BIC vary dramatically, which frequently leads serious consequences. However, at present BIC does not attract enough attention in clinic. In order to prevent and treat BIC more effectively, the authors suggest that it is necessary to strengthen coagulation surveillance, operation management, infection control, rational application of drugs, prevention and treatment of deep vein thrombosis, relative clinical and basic research, and others.
- Burns /
- Coagulopathy /
- Surveillance /
- Treatment
所有作者均声明不存在利益冲突

HTML全文

参考文献(33)

[1]	罗高兴,李海胜.烧伤可被视为一种慢性疾病[J].中华烧伤与创面修复杂志,2022,38(12):1101-1104.DOI: 10.3760/cma.j.cn501225-20221010-00444.
[2]	BallRL,KeylounJW,Brummel-ZiedinsK,et al.Burn-induced coagulopathies: a comprehensive review[J].Shock,2020,54(2):154-167.DOI: 10.1097/SHK.0000000000001484.
[3]	PusateriAE,LeTD,KeylounJW,et al.Early abnormal fibrinolysis and mortality in patients with thermal injury: a prospective cohort study[J].BJS Open,2021,5(2):zrab017.DOI: 10.1093/bjsopen/zrab017.
[4]	LiuA,MinasianRA,ManiagoE,et al.Venous thromboembolism chemoprophylaxis in burn patients: a literature review and single-institution experience[J].J Burn Care Res,2021,42(1):18-22.DOI: 10.1093/jbcr/iraa143.
[5]	SherrenPB,HusseyJ,MartinR,et al.Lethal triad in severe burns[J].Burns,2014,40(8):1492-1496.DOI: 10.1016/j.burns.2014.04.011.
[6]	IbaT,LevyJH.Sepsis-induced coagulopathy and disseminated intravascular coagulation[J].Anesthesiology,2020,132(5):1238-1245.DOI: 10.1097/ALN.0000000000003122.
[7]	GiustozziM,EhrlinderH,BongiovanniD,et al.Coagulopathy and sepsis: pathophysiology, clinical manifestations and treatment[J].Blood Rev,2021,50:100864.DOI: 10.1016/j.blre.2021.100864.
[8]	KingDR,NamiasN,AndrewsDM.Coagulation abnormalities following thermal injury[J].Blood Coagul Fibrinolysis,2010,21(7):666-669.DOI: 10.1097/MBC.0b013e32833ceb08.
[9]	BartlettRH,FongSW,MarrujoG,et al.Coagulation and platelet changes after thermal injury in man[J].Burns,1981,7(5):370-377.DOI: 10.1016/0305-4179(81)90013-9.
[10]	GengK,LiuY,YangY,et al.Incidence and prognostic value of acute coagulopathy after extensive severe burns[J].J Burn Care Res,2020,41(3):544-549.DOI: 10.1093/jbcr/irz178.
[11]	肖昆,赵斐,廖新成,等.早期纠正凝血功能障碍降低大面积烧伤成年患者28 d病死率[J].中南大学学报(医学版),2021,46(8):851-857.DOI: 10.11817/j.issn.1672-7347.2021.190817.
[12]	LiQ,ZhangT,WangL,et al.Clinical significance of R-TEG in severe burn patients with coagulation dysfunction[J].Injury,2022,53(12):3993-3999.DOI: 10.1016/j.injury.2022.09.061.
[13]	PratNJ,HerzigMC,KreyerS,et al.Platelet and coagulation function before and after burn and smoke inhalation injury in sheep[J].J Trauma Acute Care Surg,2017,83(1 Suppl 1):S59-65.DOI: 10.1097/TA.0000000000001472.
[14]	KeylounJW,LeTD,Brummel-ZiedinsKE,et al.Inhalation injury is associated with endotheliopathy and abnormal fibrinolytic phenotypes in burn patients: a cohort study[J].J Burn Care Res,2022,43(2):432-439.DOI: 10.1093/jbcr/irab102.
[15]	MarsdenNJ,LawrenceM,DaviesN,et al.The effect of the acute inflammatory response of burns and its treatment on clot characteristics and quality: a prospective case controlled study[J].Burns,2020,46(5):1051-1059.DOI: 10.1016/j.burns.2019.11.008.
[16]	KeylounJW,LeTD,OrfeoT,et al.Assessing factor V antigen and degradation products in burn and trauma patients[J].J Surg Res,2022,274:169-177.DOI: 10.1016/j.jss.2021.12.049.
[17]	McDonoughMM,KeylounJ,OrfeoT,et al.A natural history study of coagulopathy in a porcine 40% total body surface area burn model reveals the time-dependent significance of functional assays[J].Burns,2022,48(8):1805-1815.DOI: 10.1016/j.burns.2022.08.016.
[18]	GuilabertP,MartinN,UsúaG,et al.Coagulation alterations in major burn patients: a narrative review[J].J Burn Care Res,2023,44(2):280-292.DOI: 10.1093/jbcr/irac177.
[19]	LiuJ,LiuY,LiuS,et al.Hypocoagulation induced by broad-spectrum antibiotics in extensive burn patients[J/OL].Burns Trauma,2019,7:13[2022-12-23].https://pubmed.ncbi.nlm.nih.gov/31058197/.DOI: 10.1186/s41038-019-0150-7.
[20]	MartínN,GuilabertP,AbarcaL,et al.Coagulation abnormalities following nexobrid use: a case report[J].J Burn Care Res,2018,39(6):1067-1070.DOI: 10.1093/jbcr/irx044.
[21]	MatkovicE,LindholmPF.Role of viscoelastic and conventional coagulation tests for management of blood product replacement in the bleeding patient[J].Semin Thromb Hemost,2022,48(7):785-795.DOI: 10.1055/s-0042-1756192.
[22]	MarsdenNJ,VanM,DeanS,et al.Measuring coagulation in burns: an evidence-based systematic review[J].Scars Burn Heal,2017,3:2059513117728201.DOI: 10.1177/2059513117728201.
[23]	NikolaidouE,KakagiaD,KaldoudiE,et al.Coagulation disorders and mortality in burn injury: a systematic review[J].Ann Burns Fire Disasters,2022,35(2):103-115.
[24]	LonicD,HeidekruegerPI,BosselmannT,et al.Is major burn injury associated with coagulopathy? The value of thrombelastometry in the detection of coagulopathy in major burn injury: a prospective observational study[J].Clin Hemorheol Microcirc,2020,76(2):299-308.DOI: 10.3233/CH-209210.
[25]	DomínguezA,AlsinaE,LandínL,et al.Transfusion requirements in burn patients undergoing primary wound excision: effect of tranexamic acid[J].Minerva Anestesiol,2017,83(4):353-360.DOI: 10.23736/S0375-9393.16.10992-7.
[26]	LiN,ChenH,JiangT,et al. Thrombosis and infections of peripherally inserted central catheters in burn patients: a 3-year retrospective study and a systematic review[J].Burns,2022,48(8):1980-1989.DOI: 10.1016/j.burns.2021.12.008.
[27]	TracyLM,CameronPA,SingerY,et al.Venous thromboembolism prophylaxis practice and its association with outcomes in Australia and New Zealand burns patients[J/OL].Burns Trauma,2021,9:tkaa044[2022-12-23].https://pubmed.ncbi.nlm.nih.gov/33654696/.DOI: 10.1093/burnst/tkaa044.
[28]	VermaakPV,D'AstaF,ProvinsJ,et al.Thromboprophylaxis in adult and paediatric burn patients: a survey of practice in the United Kingdom[J].Burns,2019,45(6):1379-1385.DOI: 10.1016/j.burns.2019.04.003.
[29]	AhujaRB,BansalP,PradhanGS,et al.An analysis of deep vein thrombosis in burn patients (part II): a randomized and controlled study of thrombo-prophylaxis with low molecular weight heparin[J].Burns,2016,42(8):1693-1698.DOI: 10.1016/j.burns.2016.08.007.
[30]	TagamiT,MatsuiH,MoroeY,et al.Antithrombin use and 28-day in-hospital mortality among severe-burn patients: an observational nationwide study[J].Ann Intensive Care,2017,7(1):18.DOI: 10.1186/s13613-017-0244-y.
[31]	SagrisM,TzoumasA,KokkinidisDG,et al.Invasive and pharmacological treatment of deep vein thrombosis: a scoping review[J].Curr Pharm Des,2022,28(10):778-786.DOI: 10.2174/1381612828666220418084339.
[32]	ShamakiGR,Soji-AyoadeD,AdedokunSD,et al.Endovascular venous interventions - a state-of-the-art review[J].Curr Probl Cardiol,2023,48(3):101534.DOI: 10.1016/j.cpcardiol.2022.101534.
[33]	GrewalSK,HedrickAL,ManL,et al.A brief review of thrombolytics for venous interventions[J].Semin Intervent Radiol,2022,39(4):394-399.DOI: 10.1055/s-0042-1757318.